10% Shareholder Casdin Partners Files Intent to Sell $6.69M in BLFS Stock
BLFS sits 29% above its 52-week low of $17.86 on elevated volume (2.4× avg).
Summary
A major institutional investor, Casdin Partners, intends to sell $6.69 million worth of BioLife Solutions stock, signaling potential selling pressure.
Key Events · Ownership and Investor Activity · BLFS
-
Intent to Sell Shares
Casdin Partners Master Fund, L.P., a 10% shareholder, filed a Form 144 indicating its intent to sell 300,000 shares of common stock.
-
Significant Transaction Value
The proposed sale has an approximate market value of $6.69 million, which is a notable amount for the company.
-
Part of Ongoing Selling Pattern
This filing contributes to a pattern of Form 144 filings from the company in the last 90 days, suggesting continued institutional selling activity.
Analysis · BLFS · Industrial Applications And Services
Casdin Partners Master Fund, a 10% shareholder, has filed a Form 144 indicating its intent to sell 300,000 shares of BioLife Solutions common stock, valued at approximately $6.69 million. This represents a notable disposition by a significant institutional investor, potentially adding selling pressure to the stock. This follows a pattern of Form 144 filings from the company in recent months.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BLFS was trading at $23.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $17.86 to $29.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.